Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Keratins 6, 16, and 17 increase in damaged or diseased skin and may help diagnose skin issues.

Tph cells are linked to the severity of systemic lupus erythematosus.

Targeting Vδ1+T-cells may help treat alopecia areata.

Only one of the two K16 genes on chromosome 17 makes a functional protein for keratin filaments.

Enhancing Tregs can protect against alopecia areata.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

People with severe hair loss have higher levels of a protein called interleukin 17 in their blood.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Keratin 17 is important for skin's response to radiation, affecting many genes and cell division.

Human thymus has stem cells that can self-renew and maintain their identity.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

People with acne have more CD4+ immune cells in their skin than healthy people.

Type XVII collagen helps control skin cell growth and may have anti-aging effects.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Type XVII collagen helps control skin cell growth and could be a target for anti-aging treatments.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.